92534 ⎘
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
Sub-classes:Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
#2Substituted bicyclic compounds
#3Substituted bicyclic compounds
#4Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
#5Isotope enhanced ambroxol for long lasting autophagy induction
#6Adamantylmethylamine derivative and use thereof as pharmaceutical
#7Nitrated hydrocarbons, derivatives, and processes for their manufacture
#8Isotope enhanced ambroxol for long lasting autophagy induction
#9Bicyclic compounds
#10Substituted bicyclic compounds
#11SHIP1 MODULATORS AND METHODS RELATED THERETO
#12LSD1 inhibitors and uses thereof
#13CRYSTALLINE SOLID FORMS OF THE ACETATE SALT OF (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(AMINOMETHYL)-7A-METHYL-1-METHYLENEOCTAHYDRO-1H-INDEN-5-YL)-3-(HYDROXYMETHYL)-4-METHYLCYCLOHEXANOL
#14Cycloalkylamines as monoamine reuptake inhibitors
#15Macrocyclic ghrelin receptor modulators and methods of using the same
#16Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(aminomethyl)-7A-methyl-1-methyleneoctahydro-1H-inden-5-YL)-3- (hydroxymethyl)-4-methylcyclohexanol
#17Nitrated hydrocarbons, derivatives, and processes for their manufacture
#18Substituted bicyclic compounds
#19SHIP1 MODULATORS AND METHODS RELATED THERETO
#20PHENYL SUBSTITUTED CYCLOALKYLAMINES AS MONOAMINE REPUTAKE INHIBITORS
#21Substituted bicyclic compounds
#22Macrocyclic ghrelin receptor modulators and methods of using the same
#23Crystalline solid forms of the acetate salt of (1S,3S,4R)-4-((3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
#24SHIP1 modulators and methods related thereto
#25Bicyclic compounds
#26Substituted bicyclic compounds
#27Nitrated hydrocarbons, derivatives, and processes for their manufacture
#28Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#29Bicyclic compounds
#30Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#31INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#32Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#33Process for the Preparation of O-Desmethyl Venlafaxine and Intermediate for Use Therein
#34Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#35Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#36Cycloalkylamines as monoamine reuptake inhibitors
#37Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#38INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#39Substituted 4-aminocyclohexane derivatives
#40Synthesis of galanal compounds and analogues thereof
#41Amine derivative compounds for treating ophthalmic diseases and disorders
#42NICOTINIC RECEPTOR NON-COMPETITIVE MODULATORS
#43Tetrahydronaphthalenyl compounds useful as sipi agonists
#44Compounds for treating ophthalmic diseases and disorders
#45Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#46Benzocycloheptane and benzoxepine derivatives
#47Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
#48Inhibitors of the shiga toxins trafficking through the retrograde pathway
#49Cyclohexane compounds and their use as antibiotics
#50Substituted 4-aminocyclohexane derivatives
#51NOVEL PIPERIDINO-DIHYDROTHIENOPYRIMIDINE SULFOXIDES AND THEIR USE FOR TREATING COPD AND ASTHMA
#52Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#53Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#54ORGANIC COMPOUNDS
#55Benzocycloheptane and benzoxepine derivatives
#56N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
#57Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
#58Indene derivatives as pharmaceutical agents
#59Substituted 4-aminocyclohexane derivatives
#60Process for the preparation of O-desmethyl venlafaxine and intermediate for use therein
#61Styrenyl derivative compounds for treating ophthalmic diseases and disorders
#62FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#63Amine derivative compounds for treating ophthalmic diseases and disorders
#64Amine derivative compounds for treating ophthalmic diseases and disorders
#65Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#66NON-ACIDIC CYCLOPENTANE HEPTANOIC ACID, 2-CYCLOALKYL OR ARYLALKYL DERIVATIVES AS THERAPEUTIC AGENTS
#67Inhibitors of the Shiga toxins trafficking through the retrograde pathway
#68COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA
#69Methods for Preparing S1P Receptor Agonists and Antagonists
#70INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS
#71Aminoalcohol compounds, precursors, and methods of preparation and use
#72New Terpenes And Macrocycles
#73Methods of use of antiviral compounds
#74Hydroxymethylcyclohexylamines
#75Benzocycloheptane and benzoxepine derivatives
#76Nitrated hydrocarbons, derivatives, and processes for their manufacture
#77Indene derivatives as pharmaceutical agents
#78Benzyl cycloalkyl sphingosine 1-phosphate receptor modulators
#79Cycloalkylamines as monoamine reuptake inhibitors
#80Indene derivatives as pharmaceutical agents
#81Bridged six-membered ring compounds
#82Compounds for treating ophthalmic diseases and disorders
#83Chiral cyclic β-amino acids and their derivatives, pharmaceutical compositions containing them and the use of such compounds
#84SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY
#85Amine derivative compounds for treating ophthalmic diseases and disorders
#86SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
#87Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
#88Aminoindane derivative or salt thereof
#89Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders
#90Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#91Sphingosine-1-phosphate receptor agonist and antagonist compounds
#92Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
#93Macrocyclic ghrelin receptor modulators and methods of using the same
#94Organocatalysts and methods of use in chemical synthesis
#95Process for the diastereoselective alkylation of an ether oxime of the compound nopinone and novel intermediates for the synthesis of diastereospecific 2-amino-nopinone derivatives substituted on carbon 3
#96Cycloalkylamines as monoamine reuptake inhibitors
#97Cyclic amine derivative or salt thereof
#98Process for preparation of phenethylamine derivatives
#99Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4-pyrimidinyl)-amino-2-cyclopentenyl-1-methanol
#100Monoamine re-uptake inhibitors and methods relating thereto
#101Process for the preparation of aminoalcohol derivatives and their further conversion to (1R, 4S)-4(2-amino-6-chloro-5-formamido-4- pyrimidinyl)-amino-2-cyclopentenyl-1-methanol
#102Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
#103Manufacture of phenyl ethylamine compounds, in particular venlafaxine
#104Indene derivatives as pharmaceutical agents